Recombinant Human Maspin Protein，His

Maspin, a serine protease inhibitor belonging to the family of serpin proteins, has garnered significant attention in cancer research due to its dual role as a tumor suppressor. Initially identified in the context of breast cancer, Maspin is expressed at high levels in normal epithelial tissues but often shows reduced expression in various malignancies, suggesting its potential role in tumor progression and metastasis. Studies have revealed that Maspin functions by inhibiting cell migration and invasion, thus contributing to the suppression of tumor spread. Moreover, its ability to interact with several cellular pathways highlights its importance in regulating cell adhesion and inducing apoptosis in cancer cells. The recombinant production of Maspin has enabled researchers to investigate its biological functions in detail, including its mechanisms of action and therapeutic potential. By providing a purified source of this protein, recombinant Maspin facilitates the exploration of its efficacy in preclinical models, offering insights into its role as a biomarker for cancer prognosis and a potential target for novel therapeutic strategies. As the understanding of Maspin's function continues to evolve, studies are increasingly focusing on its utility not only in breast cancer but also in other malignancies, emphasizing its promise in advancing cancer biology and treatment approaches.